Biotech Series C Investors & VC Firms
430 firms in this list, with a median first check of $648K. 101 of them lead rounds. Generated from verified public data and updated continuously.
Sodero
NantesSeed–Late Stage$162K – $5.4M
19 people
Expon Capital
LuxembourgSeed–Growth$550K – $1.6M
5 people
CTI Life Sciences Fund L.P.
MontréalSeed–Late Stage
9 people
LifeSci Venture Partners
New YorkSeries A–Series C
6 people
Gilead Sciences
Foster CitySeries B–Late Stage
19 people
Quadrille Capital
ParisSeed–Late Stage
15 people
Bridge Bank
San FranciscoSeed–Late Stage
16 people
Synthesis Capital
LondonSeries A–Series C
17 people
Mithril Capital Management
AustinSeries B–Growth
5 people
AMR Action Fund
BostonSeed–Growth
13 people
Excel Venture Management
BostonSeries A–Late Stage$1M – $5M
7 people
APERTURE Venture Partners
New YorkSeed–Series C$1M – $5M
4 people
Seroba Life Sciences
DublinSeed–Growth$540K – $7.6M
13 people
IDG Capital Vietnam
HanoiSeed–Late Stage$250K – $3M
13 people
Sambrinvest
CharleroiSeries A–Late Stage
13 people
AbCellera
VancouverSeries B–Late Stage
26 people
Hillhouse Capital
ChangyangSeed–Series C$500K
7 people
Commodore Capital
New YorkSeries C–Late Stage
16 people
Luminous Ventures
ShanghaiSeed–Growth
13 people
Coinvest Capital
VilniusPre-Seed–Growth$55K – $580K
9 people
Panakes Partners
MilanSeed–Growth
14 people
Hikma Ventures
LondonSeed–Growth$5M
13 people
SBI Investment
TokyoPre-Seed–Growth
6 people
Harmonix Fund
La QuintaSeed–Series C
7 people
Related lists
Biotech Investors & VC Firms (2504)Biotech Seed Investors & VC Firms (2043)Series C Investors & VC Firms (1709)Biotech Series A Investors & VC Firms (1638)Biotech Investors & VC Firms in North America (1618)Biotech Investors & VC Firms in United States (1466)Biotech Investors & VC Firms in Europe (961)Series C Investors & VC Firms in North America (942)Biotech Pre-Seed Investors & VC Firms (931)Biotech Investors & VC Firms in Global (826)
Data sourced from public filings and firms' own websites — see our methodology.























































































